NUGLEFO Trademark

Trademark Overview

On Wednesday, August 27, 2014, a trademark application was filed for NUGLEFO with the United States Patent and Trademark Office. The USPTO has given the NUGLEFO trademark a serial number of 86378039. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 15, 2023. This trademark is owned by Glaxo Group Limited. The NUGLEFO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
nuglefo

General Information

Serial Number86378039
Word MarkNUGLEFO
Filing DateWednesday, August 27, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 15, 2023
Registration Number5211528
Registration DateTuesday, May 30, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 21, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "NUGLEFO" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 15, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Friday, December 15, 2023CANCELLED SEC. 8 (6-YR)
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, May 30, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, December 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 30, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, April 25, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Friday, March 10, 2017NOTICE OF ALLOWANCE CANCELLED
Friday, March 10, 2017TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, August 23, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 22, 2016SOU EXTENSION 2 GRANTED
Monday, August 15, 2016SOU EXTENSION 2 FILED
Monday, August 15, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, March 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 14, 2016SOU EXTENSION 1 GRANTED
Thursday, February 11, 2016SOU EXTENSION 1 FILED
Monday, March 14, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 11, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, September 15, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 21, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 21, 2015PUBLISHED FOR OPPOSITION
Wednesday, July 1, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 18, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 17, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 17, 2015PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, June 17, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 15, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 15, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 8, 2015ASSIGNED TO LIE
Monday, June 1, 2015TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, December 11, 2014NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, December 11, 2014LETTER OF SUSPENSION E-MAILED
Thursday, December 11, 2014SUSPENSION LETTER WRITTEN
Thursday, December 11, 2014ASSIGNED TO EXAMINER
Tuesday, September 9, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 30, 2014NEW APPLICATION ENTERED

Related Keywords

nuglefo pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological